Search

Your search keyword '"Risi E"' showing total 117 results

Search Constraints

Start Over You searched for: Author "Risi E" Remove constraint Author: "Risi E"
117 results on '"Risi E"'

Search Results

1. Risk assessment of Disease Recurrence (DR) through serum metabolomics analysis in elderly patients (pts) with early breast cancer (eBC)

2. 148P Serum metabolomics based risk assessment of disease recurrence in elderly patients with early breast cancer (eBC)

6. 8P Mutational analysis of circulating tumour DNA (ctDNA) in patients with ER+/HER2- advanced breast cancer (ABC) receiving palbociclib (P): Results from the TREnd trial

7. 6P Circulating tumour cells (CTCs) as biomarkers of resistance to the CDK4/6 inhibitor (CDK4/6i) palbociclib (P) in patients (pts) with ER+/HER2-negative advanced breast cancer (ABC)

10. Abstract P6-09-02: Effects of palbociclib on thymidine kinase-1 (TK1) in hormone receptor positive (HR+) breast cancer cell lines

11. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

17. A single centre pilot study aiming to determine the recommended dose (RD) of metronomic oral vinorelbine in combination with oral cyclophosphamide and bevacizumab in advanced breast cancer (ABC) patients

18. Does body mass index impact on clinical outcomes in her-2 positive metastatic breast cancer?

19. First line trastuzumab-based therapy in her2-positive metastatic breast cancer patients presenting with de novo or recurrent disease

20. First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (NEO)adjuvant trastuzumab

22. Hypertension and migraine comorbidity: prevalence and risk of cerebrovascular events: evidence from a large, multicenter, cross-sectional survey in Italy (MIRACLES study)

23. 1861 Body mass index and prognosis in HER2-positive metastatic breast cancer patients

24. 1863 First line trastuzumab- or lapatinib-based therapy in her2-positive metastatic breast cancer patients after prior (neo)adjuvant trastuzumab

26. Genetica dell’atopia

29. Detection of circulating serum galactomannan for the diagnosis of avian aspergillosis

31. Comparison of two serological tests for the diagnosis of aspergillosis in birds

32. Treatment (T) of Metastatic Colorectal Cancer (Mcrc) Patients (Pts) ≥75 Years (Y) Old in Clinical Practice: a Multicenter Analysis

34. Traitement des plaies du bréchet de canards marins hospitalisés en centre de soins de la faune sauvage

44. PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting

45. Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence

46. Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting

47. Palbociclib as single agent or in combination with the endocrine therapy received before disease progression for estrogen receptor-positive, HER2-negative metastatic breast cancer: TREnd trial

48. Treatment of Metastatic Colorectal Cancer Patients ≥75 Years Old in Clinical Practice: A Multicenter Analysis

49. L'adozione dei nuovi media da parte degli anziani: un'opportunità da cogliere e da comunicare

50. Anxiety and depression in metabolic-associated steatotic liver disease: relation with socio-demographic features and liver disease severity.

Catalog

Books, media, physical & digital resources